Literature DB >> 7005345

Endotoxin requirement for macrophage activation by lymphokines in a rapid microcytotoxicity assay.

D Taramelli, H T Holden, L Varesio.   

Abstract

A short term microcytotoxicity assay is described for studying the activation of M0 by lymphokines. Proteose-peptone-induced macrophages were purified by adherence in flat-bottomed microtiter plates and then activated by MAF-containing supernatants for 18 h. 51Cr-labeled tumor target cells were added for an additional 18 h, and then the supernatants were harvested and the % isotope release quantitated. When endotoxin-free medium and FBS were used, we found that small amounts of LPS were absolutely required for macrophage activation in this assay. The advantages of this technique included (a) good reproducibility, (b) the requirement for small number of M0, and (c) the potential of standardizing the assay and thereby testing a large number of samples. Moreover, this assay may have particular value for investigations of M0 activation by exogenous stimuli, since M0 that were not pretreated with activating agents did not exhibit cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7005345     DOI: 10.1016/0022-1759(80)90309-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Production of a neutrophil chemotactic factor by endotoxin stimulated alveolar macrophages in vitro.

Authors:  M C Snella
Journal:  Br J Exp Pathol       Date:  1986-12

2.  Fungicidal activation of murine macrophages by recombinant gamma interferon.

Authors:  L Beaman
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

3.  Augmentation of c-fos mRNA expression by activators of protein kinase C in fresh, terminally differentiated resting macrophages.

Authors:  D Radzioch; B Bottazzi; L Varesio
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

4.  Development of hyporesponsiveness of natural killer cells to augmentation of activity after multiple treatments with biological response modifiers.

Authors:  T Saito; R Ruffman; R D Welker; R B Herberman; M A Chirigos
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

5.  Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon.

Authors:  W C Koff; W E Fogler; J Gutterman; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals.

Authors:  R T Dean; J L Virelizier
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

7.  Stimulation of murine splenocytes by melatonin and methoxytryptamine.

Authors:  S F Sze; W K Liu; T B Ng
Journal:  J Neural Transm Gen Sect       Date:  1993

8.  Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma.

Authors:  J L Pace; S W Russell; R D Schreiber; A Altman; D H Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

9.  Lack of binding of bacterial lipopolysaccharide to mouse lung macrophages and restoration of binding by gamma interferon.

Authors:  K S Akagawa; T Tokunaga
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

10.  Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.

Authors:  L P Svedersky; C V Benton; W H Berger; E Rinderknecht; R N Harkins; M A Palladino
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.